Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells

By Suzuki Shinsuke   Ishikawa Kazuo  

International Journal of Oncology, Vol. 44, Iss. 3, 2014-03 ,pp. : 912-917

Spandidos Publications

Access to resources Recommend Favorite

Epidermal growth factor receptor – targeted molecular therapeutics for head and neck squamous cell carcinoma

By Egloff Ann Marie   Grandis Jennifer  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 639-647

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Squamous Cell Carcinoma of the Head and Neck in the Metastatic and Refractory Settings: Advances in Chemotherapy and the Emergence of Small Molecule Epidermal Growth Factor Receptor Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 666-673

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC)

By Nagalakshmi K.   Jamil Kaiser   Pingali Usharani   Reddy M. Vishnuvardhan   Attili Suresh S. V.  

Biomarkers, Vol. 19, Iss. 3, 2014-05 ,pp. : 198-206

Informa Healthcare

Access to resources Recommend Favorite

In vitro study of normoxic epidermal growth factor receptor–induced hypoxia‐inducible factor‐1‐alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti–epidermal growth factor receptor therapy

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1150-1162

John Wiley & Sons Inc

Access to resources Recommend Favorite